Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy

Antivir Ther. 2010;15(4):681-5. doi: 10.3851/IMP1563.

Abstract

Fulminant myocarditis is a rare inflammatory heart disease affecting relatively young adults. We describe a case of a 27-year-old male with acute onset severe heart failure. A rapid and accurate diagnostic approach suggested parvovirus B19 as the most probable cause for this fulminant viral myocarditis. Initial haemodynamic support, intensive immunosuppressive and antiviral therapy resulted in a complete recovery within 2 weeks. This case demonstrates the importance of a detailed diagnosis, allowing better classification of the underlying pathology and subsequent targeted treatment.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Myocarditis / complications
  • Myocarditis / diagnosis
  • Myocarditis / drug therapy*
  • Myocarditis / virology
  • Parvoviridae Infections / complications
  • Parvoviridae Infections / diagnosis
  • Parvoviridae Infections / drug therapy*
  • Parvoviridae Infections / virology
  • Parvovirus B19, Human / drug effects*
  • Parvovirus B19, Human / genetics
  • Parvovirus B19, Human / isolation & purification
  • Polymerase Chain Reaction
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Immunosuppressive Agents